Stock

Hims & Hers Health Inc.

000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol HIMS:xnys
Currency USD
united-states
New York Stock Exchange
Open Closed
15 minutes delayed
Data provided by Cboe Global Markets
This information is not currently available for this instrument. Refresh the page or try again later.

Chart

This information is not currently available for this instrument. Refresh the page or try again later.
Open account to access more charting and analysis tools

Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer

About Hims & Hers Health Inc.

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Sector Healthcare
Industry -
Market Cap 8bn
Data provided by FactSet Research Systems / Morningstar

Hims & Hers Health, Inc. (HIMS) is a US-based telehealth company that provides direct-to-consumer healthcare services and wellness products through a digital platform. Founded in 2017 and headquartered in San Francisco, California, the company connects users with licensed healthcare professionals for treatment in areas such as mental health, dermatology, sexual health, and general wellbeing.

Its platform supports asynchronous and live consultations, with personalised treatment plans and prescriptions delivered directly to patients. The company operates under two consumer brands: Hims (targeted at men) and Hers (targeted at women), offering both subscription-based and one-time purchase options.

Hims & Hers also sells over-the-counter health and personal care products via its website and selected retail partners. Its vertically integrated model combines clinical services, pharmacy operations, and proprietary technology to support scalable, accessible care.

Hims & Hers Health is listed on the New York Stock Exchange (NYSE).

Data provided by Saxo

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992